Lung Support Articles & Analysis
6 news found
(NASDAQ: XAIR) a medical device and biopharmaceutical company focused on developing inhaled nitric oxide (NO) for the treatment of patients with respiratory conditions, including serious lung infections and pulmonary hypertension, and, through its affiliate Beyond Cancer, Ltd., ultra-high concentration nitric oxide (UNO) for the treatment of solid tumors, today announced ...
FDA clearance of the Hemolung is a game-changer for the treatment of these critically ill patients and will usher in a new era of extracorporeal lung support,” said Steven Conrad, MD, PhD, MCCM, Medical Director at ALung and Professor of Medicine at Louisiana State University Health Sciences Center. ...
The presentation unveils the latest results of the preclinical evaluation of CorWave’s cardiac support device, validating the hemocompatibility, durability and hemodynamic performance of the LVAD. ...
ByCorWave
tiakis BIOTECH AG today announced the publication of research results by Alcazar et al. from Stanford University on a new mechanism by which Elafin rescues lung cell survival in the lung of newborn mice subjected to mechanical ventilation. Neonatal chronic lung disease or bronchopulmonary dysplasia develops in preterm infants whose ...
This once-in-a-lifetime gathering of vintage Porsche race cars from 1950-1965 coming from around the globe will raise critical funding to directly support lung cancer research. With 3,500 attendees expected, it is anticipated to be a sell out event. ...
For more than three years, the Bonnie J. Addario Lung Cancer Foundation in San Francisco and the Joan Gaeta Lung Cancer Fund (formerly Foundation) in Atlanta, have worked tirelessly back and forth across the country in their efforts to eradicate lung cancer. ...